Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction

Clinical trial NCT06217120 · UNKNOWN

Trial details

NCT number: NCT06217120
Sponsor: Montreal Heart Institute
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Heart Failure With Preserved Ejection Fraction Microvascular Coronary Artery Disease

Start date: 2024-03-01
Primary completion: 2025-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.